Europe Medical Aesthetic Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 11.07 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Medical Aesthetic Devices Market Analysis
Europe's medical aesthetic devices market is expected to witness a CAGR of 11.07% over the forecast period.
- The COVID-19 pandemic significantly impacted the medical aesthetic devices market in Europe. While the percentage of admissions that returned to pre-pandemic levels increased to 33.8%, some areas, such as the Czech Republic, Romania, and Spain, encountered significant admissions restrictions, which slowed market growth. However, with the release of restrictions and the resumption of services, the number of aesthetic procedures in hospitals and clinics has increased, fueling demand for aesthetic devices and propelling the market growth.
- Several factors are expected to boost market growth, including the rising prevalence of obesity, growing awareness of aesthetic procedures, and increasing adoption of minimally invasive techniques. The burden of the obese population was a key driver of market growth, as 25.9% of adults in England were obese in 2021, according to the Health Survey for England. Men (68.6%) were more likely to be overweight or obese than women (59%). The rising burden of obesity in the region is anticipated to increase demand for aesthetic surgeries and devices, thus boosting market growth.
- The demand for cosmetic surgeries is also increasing, with liposuction and eyelid surgeries being popular procedures in Germany, Italy, and Spain, according to the International Society of Aesthetic Plastic Surgery. This growing trend of people's concern for appearance is expected to fuel the demand for aesthetic devices and bolster market growth. Moreover, the increasing numer of new product launches and approvals, such as Galderma's Alluzience in June 2021, is anticipated to drive market growth over the forecast period.
- However, the high cost of aesthetic procedures and poor reimbursement scenarios are likely to impede market growth. Nevertheless, the market is expected to project growth over the forecast period, owing to factors such as the high burden of obesity and the growing number of aesthetic procedures.
Europe Medical Aesthetic Devices Market Trends
Breast Implant Segment is Expected to Witness Significant Growth over the Forecast Period
- The aesthetics devices market is expected to witness significant growth in the breast implant segment over the forecast period. This growth can be attributed to several factors, including the increasing prevalence of breast cancer among the population, growing awareness about physical appearance and beauty, and the availability of a variety of breast implants.
- The rising number of breast augmentation procedures in the region is also contributing to the growth of the segment. This is driving the demand for technologically advanced aesthetic devices and breast implants. For instance, according to the International Society of Aesthetic Plastic Surgery's 2021 statistics, Germany and Spain alone performed 66,945 and 37,944 breast augmentation procedures, respectively.
- Moreover, the increasing number of product launches is making more advanced breast implants available in the region, further contributing to market growth. For example, in May 2022, GC Aesthetics, Inc. launched FixNip NRI, its Nipple Areola Complex Reconstruction Implants, to cater to women's clinical needs.
- In May 2021, GC Aesthetics launched PERLE, the next generation of breast implants, a highly innovative line of smooth breast implants with surface technology (BioQ), in Europe. This launch helped the company to offer the broadest product portfolio with a full selection of surfaces, fillings, sizes, and projections to meet every patient's and surgeon's demands for both reconstructive and aesthetic procedures.
- Therefore, the high burden of breast cancer, along with the rising number of product launches, is expected to drive the growth of the studied market over the forecast period.
Germany is Expected to Have the Significant Market Share Over the Forecast Period
Germany is anticipated to hold a significant share of the medical aesthetics market over the forecast period owing to the factors such as the high burden of breast cancer, increasing aesthetic procedures, the growing geriatric population as well as rising product launches.
As per the statistics published by the International Society of Aesthetic Plastic Surgery, about 476,951 surgical procedures and 605,942 non-surgical procedures were performed in Germany in 2021. In addition, about 66,945 breast augmentation surgical procedures and 306,296 botulinum toxin non-surgical procedures were performed in Germany in 2021. As per the same source, Germany reported 806 chemical peel procedures in 2021. Thus, the increasing number of aesthetic procedures requires medical aesthetic devices, hence propelling the market growth in Germany over the forecast period.
The rising burden of breast cancer among the population increases the need for breast surgeries which in turn is anticipated to fuel the demand for different types of breast implants, thereby propelling the market growth. For instance, as per 2023 statistics published by the Global Cancer Observatory, about 70,721 breast cancer cases are expected to be diagnosed in Germany in 2025 as compared to 69,697 cases during the pandemic. In addition, this number is projected to reach 71,799 by 2030.
Furthermore, the rising product launches in the country are also contributing to the market growth over the forecast period. For instance, in April 2022, Sinclair Pharma announced the company has received the European CE mark for Perfectha Lidocaine in the treatment of wrinkle correction, facial contouring, and volume restoration. This CE certificate results in the launch of Perfectha Lidocaine in the United Kingdom and all major European markets.
Therefore, due to the aforementioned factors, such as increasing breast cancer cases, growing demand for aesthetic procedures, and rising product launches, the studied market is expected to grow over the forecast period.
Europe Medical Aesthetic Devices Industry Overview
The European market for medical aesthetic devices is characterized by moderate fragmentation, with both small and large players operating in the market. In order to maintain their market position, these companies are adopting various key strategies such as partnerships, product approvals, and collaborations. Some of the key players in the market include Abbvie Inc. (Allergan Inc.), Boston Scientific Corporation (Lumenis Inc.), Johnson and Johnson, Alma Lasers, and Galderma Pharmaceuticals.
Europe Medical Aesthetic Devices Market Leaders
-
Johnson and Johnson
-
Alma Lasers
-
Galderma SA
-
Abbvie Inc (Allergan Inc.)
-
Boston Scientific Corporation (Lumenis Inc.)
*Disclaimer: Major Players sorted in no particular order
Europe Medical Aesthetic Devices Market News
- October 2022: Evolus, Inc. entered the British market by launching commercial operations and shipping Nuceiva (botulinum toxin type A). This move was aimed at expanding the company's presence in the European market and providing patients with a new option for aesthetic treatments.
- October 2022: GC Aesthetics received CE mark approval for its new micro-textured anatomical breast implant, the LUNA xt breast implant, under the new European Medical Device Regulation (MDR). This approval allows the company to market and distribute the implant in the European Union, providing women with an innovative option for breast augmentation surgery. The new implant features a unique design and texture that aims to enhance patient outcomes while reducing the risk of complications.
Europe Medical Aesthetic Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Obese Population
- 4.2.2 Increasing Awareness Regarding Aesthetic Procedures and Rising Adoption of Minimally Invasive Techniques
-
4.3 Market Restraints
- 4.3.1 Poor Reimbursement Scenario
- 4.3.2 High Cost of Aesthetic Procedures
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Type of Devices
- 5.1.1 Energy-Based Aesthetic Devices
- 5.1.1.1 Laser-based Aesthetic Devices
- 5.1.1.2 Radiofrequency (RF) Based Aesthetic Devices
- 5.1.1.3 Light-based Aesthetic Devices
- 5.1.1.4 Ultrasound Aesthetic Devices
- 5.1.2 Non-Energy-Based Aesthetic Device
- 5.1.2.1 Botulinum Toxin
- 5.1.2.2 Dermal Fillers and Aesthetic Threads
- 5.1.2.3 Chemical Peels
- 5.1.2.4 Microdermabrasion
- 5.1.2.5 Implants
- 5.1.2.5.1 Facial Implants
- 5.1.2.5.2 Breast Implants
- 5.1.2.5.3 Other Implants
- 5.1.2.6 Other Aesthetic Devices
-
5.2 By Application
- 5.2.1 Skin Resurfacing and Tightening
- 5.2.2 Body Contouring and Cellulite Reduction
- 5.2.3 Hair Removal
- 5.2.4 Breast Augmentation
- 5.2.5 Other Applications
-
5.3 By End-User
- 5.3.1 Hospitals
- 5.3.2 Clinics
- 5.3.3 Other End-Users
-
5.4 Geography
- 5.4.1 United Kingdom
- 5.4.2 Germany
- 5.4.3 France
- 5.4.4 Italy
- 5.4.5 Spain
- 5.4.6 Rest of Europe
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbvie Inc (Allergan Inc.)
- 6.1.2 Lumenis Inc.
- 6.1.3 Johnson & Johnson (Mentor Worldwide)
- 6.1.4 Sisram Medical (Alma Lasers)
- 6.1.5 Galderma SA
- 6.1.6 Syneron Medical Ltd
- 6.1.7 Merz Pharma GmbH & Co. KGaA
- 6.1.8 Bausch Health Companies Inc. (Solta Medical Inc.)
- 6.1.9 Cutera Inc.
- 6.1.10 Sciton Inc.
- 6.1.11 Cynosure
- 6.1.12 Human Med AG
- 6.1.13 Aerolase Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityEurope Medical Aesthetic Devices Industry Segmentation
As per the scope of the report, aesthetic devices refer to all medical devices that are used for various cosmetic procedures, which include plastic surgery, unwanted hair removal, excess fat removal, anti-aging, aesthetic implants, skin tightening, etc., that are used for beautification, correction, and improvement of the body. Aesthetic procedures include both surgical and non-surgical procedures.
The Europe medical aesthetic devices market is segmented by type of devices (energy-based aesthetic devices (laser-based aesthetic devices, radiofrequency (RF)-based aesthetic devices, light-based aesthetic devices, and ultrasound aesthetic devices), non-energy based aesthetic devices (botulinum toxin, dermal fillers and aesthetic threads, chemical peels, microdermabrasion, and implants (facial implants, breast implants, and other implants), and other aesthetic devices), application (skin resurfacing and tightening, body contouring and cellulite reduction, hair removal, breast augmentation, and other applications), end-user (hospitals, clinics, and other end-users), and geography (United Kingdom, Germany, France, Italy, Spain, and Rest of Europe).
The report offers the value (in USD million) for the above segments.
| By Type of Devices | Energy-Based Aesthetic Devices | Laser-based Aesthetic Devices | |
| Radiofrequency (RF) Based Aesthetic Devices | |||
| Light-based Aesthetic Devices | |||
| Ultrasound Aesthetic Devices | |||
| By Type of Devices | Non-Energy-Based Aesthetic Device | Botulinum Toxin | |
| Dermal Fillers and Aesthetic Threads | |||
| Chemical Peels | |||
| Microdermabrasion | |||
| Implants | Facial Implants | ||
| Breast Implants | |||
| Other Implants | |||
| Other Aesthetic Devices | |||
| By Application | Skin Resurfacing and Tightening | ||
| Body Contouring and Cellulite Reduction | |||
| Hair Removal | |||
| Breast Augmentation | |||
| Other Applications | |||
| By End-User | Hospitals | ||
| Clinics | |||
| Other End-Users | |||
| Geography | United Kingdom | ||
| Germany | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe |
Europe Medical Aesthetic Devices Market Research FAQs
What is the current Europe Medical Aesthetic Devices Market size?
The Europe Medical Aesthetic Devices Market is projected to register a CAGR of 11.07% during the forecast period (2024-2029)
Who are the key players in Europe Medical Aesthetic Devices Market?
Johnson and Johnson, Alma Lasers, Galderma SA, Abbvie Inc (Allergan Inc.) and Boston Scientific Corporation (Lumenis Inc.) are the major companies operating in the Europe Medical Aesthetic Devices Market.
What years does this Europe Medical Aesthetic Devices Market cover?
The report covers the Europe Medical Aesthetic Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Medical Aesthetic Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe Medical Aesthetic Devices Industry Report
Statistics for the 2024 Europe Medical Aesthetic Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Medical Aesthetic Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
